Suppr超能文献

转录因子 TCF1 与 RORγt 结合,构成一个调节网络,决定了稳态 Th17 细胞的状态。

Transcription factor TCF1 binds to RORγt and orchestrates a regulatory network that determines homeostatic Th17 cell state.

机构信息

Gene Lay Institute of Immunology and Inflammation, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Mass General Brigham, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Institute for Research in Biomedicine, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Bellinzona 6500, Switzerland.

Gene Lay Institute of Immunology and Inflammation, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Mass General Brigham, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

出版信息

Immunity. 2024 Nov 12;57(11):2565-2582.e6. doi: 10.1016/j.immuni.2024.09.017. Epub 2024 Oct 23.

Abstract

T helper (Th) 17 cells encompass a spectrum of cell states, including cells that maintain homeostatic tissue functions and pro-inflammatory cells that can drive autoimmune tissue damage. Identifying regulators that determine Th17 cell states can identify ways to control tissue inflammation and restore homeostasis. Here, we found that interleukin (IL)-23, a cytokine critical for inducing pro-inflammatory Th17 cells, decreased transcription factor T cell factor 1 (TCF1) expression. Conditional deletion of TCF1 in mature T cells increased the pro-inflammatory potential of Th17 cells, even in the absence of IL-23 receptor signaling, and conferred pro-inflammatory potential to homeostatic Th17 cells. Conversely, sustained TCF1 expression decreased pro-inflammatory Th17 potential. Mechanistically, TCF1 bound to RORγt, thereby interfering with its pro-inflammatory functions, and orchestrated a regulatory network that determined Th17 cell state. Our findings identify TCF1 as a major determinant of Th17 cell state and provide important insight for the development of therapies for Th17-driven inflammatory diseases.

摘要

辅助性 T 细胞 17(Th17)细胞包含一系列细胞状态,包括维持组织稳态功能的细胞和可驱动自身免疫性组织损伤的促炎细胞。鉴定决定 Th17 细胞状态的调控因子可以确定控制组织炎症和恢复稳态的方法。在这里,我们发现白细胞介素(IL)-23 是诱导促炎 Th17 细胞的关键细胞因子,其降低转录因子 T 细胞因子 1(TCF1)的表达。在成熟 T 细胞中条件性删除 TCF1 会增加 Th17 细胞的促炎潜能,即使在缺乏 IL-23 受体信号的情况下也是如此,并赋予稳态 Th17 细胞促炎潜能。相反,持续表达 TCF1 会降低促炎 Th17 潜能。从机制上讲,TCF1 与 RORγt 结合,从而干扰其促炎功能,并协调决定 Th17 细胞状态的调控网络。我们的研究结果确定 TCF1 是 Th17 细胞状态的主要决定因素,并为开发针对 Th17 驱动的炎症性疾病的治疗方法提供了重要的见解。

相似文献

引用本文的文献

6
Insights into autoimmunity and cancer.对自身免疫和癌症的见解。
Nat Immunol. 2025 Mar;26(3):342-344. doi: 10.1038/s41590-025-02078-x.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验